News Focus
News Focus
icon url

ubmmg

01/03/20 3:04 PM

#103159 RE: James salmon #103158

Will Advaxis attend the JPM conference this year? I haven't seen a PR yet, but who knows.
icon url

oakrock

01/03/20 3:07 PM

#103160 RE: James salmon #103158

Us retailers will get it last....Day 2 over a buck! Yeah! and looks like breaking through $1.00 resistance...
icon url

oakrock

01/05/20 2:26 AM

#103177 RE: James salmon #103158

I wonder if below has something to do with the rise...HOT is HOT from 12/19:

PRINCETON, N.J.--(BUSINESS WIRE)--Advaxis, Inc. (Nasdaq: ADXS), a clinical-stage biotechnology company focused on the development and commercialization of immunotherapy products, today announced it has submitted an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for the initiation of a Phase 1 clinical study of ADXS-504, the Company’s ADXS-HOT drug candidate for prostate cancer.